Hostname: page-component-586b7cd67f-tf8b9 Total loading time: 0 Render date: 2024-11-28T06:39:47.077Z Has data issue: false hasContentIssue false
  • English
  • Français

Use of fluoxetine in patients with diabetes mellitus

Published online by Cambridge University Press:  02 January 2018

Gill Salmon
Gill Salmon*
Affiliation:
Child and Family Service, Brookside Clinic, Station Way, Aylesbury, Bucks HP20 2SQ
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Although pharmaceutical companies report side effects that may occur with use of their medications, little data on specific groups of patients that may be at risk of particular side effects is available (Katz et al, 1991). Patients with diabetes mellitus form an important group for psychiatrists since the occurrence of depression is relatively common with this group and guidance on its treatment is lacking.

Type
Drug Information Quarterly
Information
Psychiatric Bulletin , Volume 19 , Issue 9 , September 1995 , pp. 553 - 554
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © Royal College of Psychiatrists, 1995

References

Ahren, B., Taborsky, G. J. Jr. & Porte, D. Jr. (1986) Neuropeptide versus cholinergic and adrenergic regulation of islet hormone secretion. Diabetologia, 29, 827–836.Google Scholar
Lear, J. & Burden, A. C. (1992) Fluoxetine side-effects mimicking hypoglycemia (letter). Lancet, 339, 1296.Google Scholar
Katz, L. M., Fochtmann, L. J. & Pato, M. T. (1991) Clomipramine, fluoxetine and glucose control. Annals of Clinical Psychiatry, 3/4, 271–274.Google Scholar
Kutnowski, M., Daubresse, J. C., Friedman, H., et al (1992) Fluoxetine therapy in obese diabetic and glucose intolerant patients. International Journal of Obesity, 16(Suppl. 4), 63–66.Google Scholar
Potter Van Loon, B. J., Radder, J. K., Frolich, M., et al (1992) Fluoxetine increases insulin action in obese type 11 (non-insulin dependent) diabetic patients. International Journal of Obesity, 16(Suppl. 4), 55–61.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.